Recently, in a study about A>I(G) RNA editing across all available cancer cell lines, only two RNA-edited sites, Chr19:58355670 (A/G) in ZNF587B and Chr20:36147563 (T/C) in BLCAP, were associated with sensitivity to doxorubicin specifically in BC cell lines [31]. The gene discussed is BLCAP; the disease is breast cancer.